Kerala Ayurveda AGM 2026 approves 6.55 lakh shares

AGM outcome: four resolutions placed, key special resolution passed

Kerala Ayurveda Limited held its 34th Annual General Meeting (AGM) on September 28, 2026, where shareholders approved multiple items put up by the Board of Directors. The meeting included approval of the FY26 standalone and consolidated financial statements and a special resolution linked to capital restructuring. The special resolution relates to a preferential issue of equity shares to Katra Holding Private Limited, a promoter group entity. As per the AGM proceedings, the company has stated that the results of the e-voting process are expected to be filed separately after the scrutinizer’s report. The AGM was conducted through Video Conferencing or Other Audio-Visual Means (VC/OAVM), consistent with the company’s stated meeting mode. The company had earlier indicated that shareholder approval for the preferential issue was required under SEBI regulations.

Meeting details: timing, attendance, and format

The AGM commenced at 11:00 am and concluded at 12:35 pm, according to the disclosed proceedings. A total of 44 members, including authorised representatives, attended the virtual meeting. The company provided voting facilities to shareholders through remote e-voting ahead of the meeting. Members who were present in the AGM and had not voted remotely were allowed to cast votes during the session. The voting line remained open for an additional 15 minutes after the conclusion of the proceedings. These operational details reflect how the company enabled shareholder participation and voting in a VC/OAVM format.

Remote e-voting window and expected filing of results

Kerala Ayurveda provided remote e-voting from September 25, 2026, to September 27, 2026. This allowed shareholders to vote on the resolutions ahead of the meeting date. For those who did not participate in remote voting, the company allowed voting during the AGM session itself, with the additional 15-minute post-close window. The company has indicated that the results of the e-voting process are expected to be filed separately following the scrutinizer’s report. This suggests the detailed voting outcomes and confirmations will be disclosed in a subsequent filing.

Resolutions presented at the 34th AGM

The Board of Directors presented four items for shareholder approval. These covered adoption of financial statements, a director’s reappointment, ratification of cost auditor remuneration, and the preferential issue of equity shares as part of capital restructuring.

Preferential issue: revised size, price, and consideration

The special resolution approved the issuance of 6,55,000 equity shares on a preferential basis. The preferential issue is to Katra Holding Private Limited, described as a promoter group entity. The issue price cited is ₹190.37 per share. The consideration for the allotment is proposed through adjustment of an unsecured loan, as stated in the resolution description. A corrigendum also noted that the preferential issue was revised from 7,20,000 shares to 6,55,000 shares to Katra Holding at ₹190.37 each, with the issue size indicated at approximately ₹12.47 crore. The same corrigendum also mentioned a post-issue stake of 9.41%.

What changed: corrigendum reduced shares from 7.2 lakh to 6.55 lakh

The company had communicated an approval for a preferential allotment of up to 7.2 lakh equity shares to Katra Holding Private Limited at ₹190.37 per share. Subsequently, a corrigendum revised the preferential issue from 7,20,000 to 6,55,000 equity shares at the same price. The corrigendum was published in Financial Express and Deepika on September 23, 2026, in connection with the AGM scheduled for September 28, 2026 at 11:00 AM IST via VC/OAVM. The update is material because the final shareholder-approved issuance quantity aligns with the revised number of 6,55,000 shares.

Board timeline: September 4 meeting and the AGM call

Kerala Ayurveda’s board met on September 4, 2026, to consider a preferential issue of equity shares and to convene its 34th AGM. The board also approved convening the AGM on Monday, September 28, 2026, at 11:00 am through VC/OAVM. The company stated that the AGM would seek shareholder approval for the preferential issue, as required under SEBI regulations. This sequence sets out a clear timeline where the board initiated the proposal earlier in the month and then routed it through shareholders at the scheduled AGM.

Key facts at a glance

The AGM and the preferential issue include several data points that matter for shareholders following the company’s corporate actions and governance calendar.

Market impact: what the approved issue implies, based on disclosed terms

The disclosed structure indicates that the company is using a preferential allotment to a promoter group entity and adjusting an unsecured loan as consideration. At the stated price of ₹190.37 per share and the revised quantity of 6,55,000 shares, the transaction value was indicated at about ₹12.47 crore. For investors tracking changes in share capital and promoter holding, the corrigendum’s reference to a post-issue stake of 9.41% provides a concrete datapoint about the ownership position after the allotment. The company has not provided voting percentages for the AGM resolutions in the provided information, and it has said the e-voting results will be filed separately after the scrutinizer’s report. As a result, the immediate market-relevant information available is the approved quantity, the identity of the allottee, the price, and the loan-adjustment consideration.

Why this matters: governance, disclosures, and next filings

From a governance standpoint, the AGM covered standard annual items such as adoption of audited financial statements and ratification of auditor remuneration, along with a capital-related special resolution. The preferential issue is notable because it involves a promoter group entity and a specified mechanism of settling an unsecured loan through equity issuance. The company’s statement that e-voting outcomes will be filed separately makes the next disclosure important for shareholders who want the final voting breakdown and the scrutinizer’s confirmation. Until those filings are made, the public record from the AGM primarily establishes that the resolutions were placed and approved, and that the meeting was conducted with remote and in-meeting voting facilities.

Conclusion

Kerala Ayurveda Limited’s 34th AGM on September 28, 2026 approved FY26 financial statements and cleared a special resolution to issue 6,55,000 equity shares to Katra Holding Private Limited at ₹190.37 per share through adjustment of an unsecured loan. The company has indicated that detailed e-voting results will be filed separately after receipt of the scrutinizer’s report.